Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Grainne who wrote (1232)	5/23/1998 5:05:00 PM
From: Pancho Villa	Read Replies (1) \| Respond to of 1359

To all: I currently hold no position on IPIC. You have had a chance to read my previous opinions on the company. Some people seem to belive there is value at $5. I hope people with such opinion generate enough demand to pump up the price of this puppy over 10 once more so that I can short again. IMO IPIC's RD capabilities and pipeline are more hype than substance. These folks keep on licensing "long shot" drugs in the hope their a-priori belief these drugs should work proves right. We all wish science were so easy. There are no shortcuts and/or easy victories in the pharmaceutical industry. Look at the R&D budget and staff of the succesful biotechnology players. IMO IPIC's reason for being was redux and that is gone. You cannot develop a meaningful alternative without substantial serious R&D which IPIC does not seem whiling capable of doing. Pancho